| |
| 
The term 'probiotic' is derived from the Greek,
meaning ‘for life’. Probiotics are currently defined as
‘live microorganisms which, when consumed in adequate amounts,
confer a health benefit to the host’(1).
Common descriptions for probiotics include ‘friendly’,
‘beneficial’ or ‘healthy’ bacteria.
Probiotic bacteria are generally, though not exclusively, lactic acid
bacteria and include Lactobacillus acidophilus, L. casei, L. bulgaricus,
L. plantarum, L. salivarius, L. rhamnosus, L. reuteri, Bifidobacterium
bifidum, B. longum, B. infantis and S. thermophilus. Probiotic bacteria
are used in the production of yogurt, various fermented milk products
and dietary supplements.
Lactobacilli and Bifidobacteria
are Gram-positive lactic acid-producing bacteria that constitute
a major part of the normal intestinal microflora in animals and
humans. These friendly bacteria play a key role in enhancing resistance
to colonization by exogenous, potentially pathogenic organisms.
Lactobacilli:
Lactobacilli are Gram-positive, non-spore forming rods or
coccobacilli. They have complex nutritional requirements and are
strictly fermentative, aerotolerant or anaerobic, aciduric or acidophilic.
Lactobacilli are found in a variety of habitats where rich, carbohydrate-containing
substrates are available, such as human and animal mucosal membranes,
on plants or material of plant origin, sewage and fermenting or
spoiling food(8).
Bifidobacteria:
Bifidobacteria constitute a major part of the normal intestinal
microflora in humans throughout life. They appear in the stools
a few days after birth and increase in number thereafter. The number
of bifidobacteria in the colon of adults is 1010
- 1011 CFU/gram, but this number
decreases with age. Also demographic differences affest the number
and species of bifidobacteria. Bifidobacteria are nonmotile, nonsporulating
Gram-positive rods with varying appearance. Most strains are strictly
anaerobic. B. longum may be considered as the most common species
of bifidobacteria, being found both in infant and adult feces. This
species is closely related to B. infantis, which often leads to
identification problems(8).
Below are some pictures of probiotic bacterias.
The
condition and function of the gastrointestinal tract is essential
to our well being. After the respiratory tract, the GI tract constitutes
the second largest body surface area, comparable in size to a tennis
court. During a normal lifetime, about 60 tons of food pass through
this canal.

The human intestinal microflora is highly
important to the host for several reasons. Firstly, microflora benefits
the host by increasing resistance to new colonization as well as
by protecting against the overgrowth of already-present potentially
pathogenic organisms. Another function important to the host is
the high metabolic activity of the intestinal flora. The extent
of this activity has been claimed to be similar to that of the liver.
Administration of antimicrobial agents is the most common cause
of disruption of the balance of the normal microflora and leads
to decreased resistance to colonization and to alterations in the
metabolic activities of the intestinal flora. For
thousands of years microbial cultures have been used to ferment
foods and prepare alcoholic beverages. In Genesis, references are
made to the preparation of fermented milk. Microorganisms were used
in the 19th century to prevent and cure diseases, and were added
to domestic animal feed to enhance growth. It is likely that the
first scientific assessments of probiotics were made in 1908, based
on the work of the Russian Nobel Prize Laureate Elie Metchnikoff.
He first hypothesized that a high concentration of lactobacilli
in intestinal flora were important for health and longevity in humans.
Indeed, we now know that intestinal flora plays an important role
in health: stimulating the immune system, protecting the host from
invading bacteria and viruses, aiding digestion and assimilation
of food. Yet, the importance of these bacteria in the gastro-intestinal
GI tract has been neglected for a long time, while the
focus was merely placed on enteric pathogens and other factors leading
to gastrointestinal "disorders".
The
composition of the gastrointestinal flora differs among individuals,
and also during life within the same individual. Many factors,
such as diet or climate, aging, medication (especially antibiotics),
illness, stress, pH, infection, geographic location, race, socioeconomic
circumstances, lifestyle can upset this balance(1).
Interactions of typical intestinal bacteria may also contribute
to stabilization or destabilization. A state of balance within the
microbial population within the GI tract can be called "eubiosis"
while an imbalance is termed "dysbiosis". For optimum
"gut flora balance", the beneficial bacteria, such as
the gram-positive Lactobacilli and Bifidobacteria, should predominate,
presenting a barrier to invading organisms. Around 85% of the intestinal
microflora in a healthy person should be good bacteria and 15% bad
bacteria(2).
The greater the imbalance, the greater the symptoms.
The use of probiotics may be the most natural, safe and common sense
approach for keeping the balance of the intestinal ecosystem.
|
|
The 25-35 foot long GI tract of an
adult human is estimated to harbor about 100 trillion viable bacteria.
This is approximately 10 times the total number of cells in the
human body. These live bacteria account for around 2 lbs of a
body's weight and are known as intestinal or gut flora. Viruses,
fungi and protozoa can also be present, but these normally form
only a minor component of the total resident population of microorganisms
in healthy individuals.
The density of microorganisms
in the gut flora increases dramatically from 10-1,000 CFU/ml in
the stomach to 10-100 billion CFU/gm in the large intestine(1)
and these belong to as many as 400 different species, and anaerobic
bacteria outnumber aerobic bacteria by a factor of 1000:1. Anaerobic
flora is dominated by Bacteroides spp., bifidobacteria, propionibacteria
and clostridia. Among aerobic and anaerobic bacteria enterobacteria,
mainly E.coli, and enterococci predominate. As indicated
in table 1, Bifidobacteria account for approximately 90% of the
total colonic beneficial microflora. Populations of Lactobacilli
are several orders of magnitude smaller than Bifidobacteria.
Bacteria have been estimated to constitute 35-50% of the volume
of the contents in the human colon. They profoundly influence
nutritional, physiologic and protective processes. Both direct
and indirect defensive functions are provided by the normal microbiota.
Specifically, gut bacteria directly prevent colonization by pathogenic
organisms by competing for essential nutrients or for epithelial
attachment sites. By producing antimicrobial compounds, volatile
fatty acids, and chemically modified bile acids, indigenous gut
bacteria also create a local environment that is generally unfavorable
for the growth of enteric pathogens(12).
This phenomenon is called Colonization
Resistance, which can be defined as the ability of microorganisms
belonging to the normal gut microflora to impede the implantation
of pathogens. This function of the microflora is also known as
the barrier effect. While probiotic bacteria improve colonization
resistance, consensus thinking is that the importance of lactic
acid bacteria as probiotic agents lies more in the indirect mechanisms
such as immunomodulation.
The normal or indigenous microflora of man consists of a resident
(autochtonous) part, which largely stays with the host organism,
and a transient part, which may dynamically change in composition.
This is not unique for man as it also applies to animals. The
turnover of the transient part of the microflora of the digestive
tract depends both on the composition of the resident flora or
Colonization Resitance, and on the degree of contamination (qualitatively
and quantitatively as well) of ingested food and beverages. Regarding
the latter, hygienic conditions of the environment is important.
The defense systems in the gut can be split into three parts:
the gut flora, the gut mucosa and epithelium and the related immune
system, as illustrated in Fig. 1.

Figure I: Illustration
of the natural defense systems of the intestine (Source: DanoneVitapoie)
The intestine, composed of villi and crypts,
is coated with mucus that protects the intestinal cells. At the
bottom of the crypts lie specialised cells known as Paneth cells
that are able to release antimicrobial molecules into the gut
lumen.The intestinal flora, present mainly in the colon, forms
a natural barrier to pathogens.The intestinal immune system comprises
cells disseminated beneath the epithelium and also between epithelial
cells (intraepithelial lymphocytes). Lymphocytes are also found
within more organised structures, lymphoid follicles, with a central
region of B lymphocytes and a lateral region ofT lymphocytes.
Above these structures, we find M cells, which are specialised
in transporting particles to the follicle.These areas of the intestine
are known as Peyer's patches.When a lymphocyte is activated by
a dendritic cell presenting an antigen, it leaves the mucosa in
lymph and enters the bloodstream via the thoracic canal. This
activated lymphocyte then colonises either the same mucosa or
other mucosal effector sites.
Although
less complex than the gastrointestinal microflora, the normal
vaginal microflora of a premenopausal woman is composed of a variety
of bacterial species. Anaerobes are most frequently isolated and
appear in numbers of 107 - 109
CFU/ml of vaginal secretion. Lactobacillus
spp. is the most frequently isolated genus found in the highest
numbers. They play a role in maintaining the balance of the normal
vaginal flora by producing hydrogen peroxide. It has been shown
that approximately 70% of premenopausal, healthy women harbor
hydrogen peroxide-producing lactobacilli. Corynebacterium, Staphylococcus
and Bacteroides spp. are among the anaerobes frequently isolated.
Fetuses
are sterile in the womb, but beginning with the birth process,
infants are exposed to microbes that originate from the mother
and the surrounding environment including breast milk or formula(12).
The infant tends to acquire the flora swallowed from the vaginal
fluid at the time of delivery. Because vaginal flora and intestinal
flora are similar, an infant's flora may closely mimic the intestinal
flora of the mother(15).
Another factor affecting the intestinal flora of the newborn is
delivery mode. A normal vaginal delivery commonly permits transfer
of bacteria from the mother to the infant. During cesarean deliveries,
this transfer is completely absent. These infants commonly acquire
and are colonized with flora from the hospital's environment and,
therefore, their flora may differ from maternal flora. Infants
delivered by cesarean section are colonized with more anaerobic
bacteria, especially Bacteroides, than vaginally delivered infants.
Clostridium perfringens is the anaerobic bacterium most frequently
isolated after cesarean deliveries. When colonized, cesarean delivered
infants less frequently harbor E. coli, and more often klebsiella
and enterobacteria(7).
The initial colonizing bacteria vary with the food source of the
infant. In breast-fed infants, Bifidobacteria account for more
than 90% of the total intestinal bacteria. The low concentration
of protein in human milk, the presence of specific anti-infective
proteins such as immunoglobulin A, lactoferrin, lysozyme, and
oligosacharides (prebiotics), as well as production of lactic
acid, cause an acid milieu and are the main reasons for its bifidogenic
charachtersitics. In bottle-fed infants, Bifidobacteria are not
predominant(13).
Instead enterobacteria and gram-negative organisms dominate because
of a more alkaline milieu and the absence of the prebiotic modulatory
factors present in breast milk.
The establishment of an intestinal microbial
ecology is very variable at the beginning but will become a more
stable system similar to the adult microflora by the end of the
breastfeeding period.
Other factors affecting the intestinal microflora of the infant
include geographical differences (industrialized vs. developing
countries) and administration of antibiotics in neonatal intensive
care.
Probiotics must be ingested regularly for
any health promoting properties to persist. It is possible to
manipulate the composition of the intestinal microflora in adults
through dietary supplementation with probiotics. This concept
is gaining popularity throughout the world.
The mode of action of a probiotic may include host microflora
modulation, e.g., by improvement of the microbial balance via
interaction of orally applied viable microbes with the microflora
in the digestive tract lumen, the modulation of host metabolic
activities, e.g., by stabilizing digestive enzyme pattern, and
immunomodulation, e.g., by activation and regulation of mucosa-associated
and systemic immune system responses. These modes of action are
also strain-dependent.
The intestinal microflora provides protection against a broad
range of pathogens, including certain forms of Clostridia, Escherichia
Coli, Salmonella, Shigella and Pseudomonas, as well as yeasts
such as Candida albicans.
|
A. |
Modify microflora to suppress pathogens.
|
B. |
Secrete antibacterial substances.
Probiotic bacteria produce a variety of substances that are
inhibitory to both gram-positive and gram-negative bacteria.
These include organic acids, hydrogen peroxide and bacteriocins.
These compounds may reduce not only the number of viable pathogenic
organisms but may also affect bacterial metabolism and toxin
production. This occurs through reduction of luminal pH through
the production of volatile short-chain fatty acids, mainly
acetates, propionates and butyrates. And of course, through
production of lactic acid (Bifidobacterium, Lactobacillus,
Streptococcus), leading to a reduction in colonic pH. |
C. |
Compete with pathogens to prevent their
adhesion to the intestine. |
D. |
Compete for nutrients necessary for
pathogen survi |
E. |
Antitoxin effect |
A. Promote
tight contact between epithelial cells forming a functional barrier.
B. Reducing
the secretory and inflammatory consequences of bacterial infection.
C. Enhancing
the production of defensive molecules such as mucins.
A. Probiotics
as vehicles to deliver anti-inflammatory molecules to the Intestine.
B. Enhance
signaling in host cells to reduce inflammatory response.
C. Switch
in immune response to reduce allergy.
D. Reduce
the production of inflammatory substances.
Probiotics modulate the composition of the intestinal microflora.
The survival of ingested probiotics in different parts of the
gastrointestinal tract differs between strains. As a result of
their concentration in the lumen, they contribute to transient
modulation of the microflora ecology, at least during the period
of intake. This specific change may be seen for a few days after
the start of consumption of the probiotic preparation, depending
on the capacity and dosage of the strain in question to modulate
the functioning of the gastrointestinal tract. Results show that
with regular consumption, the bacteria temporarily colonise the
lower intestine. Once consumption stops, the number of probiotic
microorganisms quickly falls (see Figure 2 below). This applies
to all probiotic supplements available in the market today
.
Figure
2
Many studies have demonstrated
significant shifts in bacterial counts in human faeces following
consumption of specific probiotic strains, generally resulting
in increased numbers of health-promoting genera (Lactobacillus
and Bifidobacterium) and decreased numbers of potentially harmful
ones (such as several strains of Clostridum, Enterococcus and
Candida). These studies, however, reflect the bacteriological
situation in faecal matter only and do not provide an accurate
picture of the situation in different parts of the gastrointestinal
tract or in the mucosal layer of the gut. Furthermore, many species
of intestinal bacteria from faecal samples cannot be cultured
on specific plates.
Probiotic bacteria modulate the metabolic activity of the gut
flora. Probiotics, being able to lower the pH in the intestinal
tract, may thus be able to interfere with the enzymatic activity
of the flora.
Qualities
of an effective probiotic dietary supplement include the following(4):
1) Must
be of human origin
2)
Exert a beneficial effect on the host
3) Be nonpathogenic and nontoxic
4) Contain a large number of viable
cells
5) Be capable of surviving and
metabolizing in the gut
6) Remain viable during storage
and use
7) Be antagonistic to pathogens.
Our
custom probiotic formulations meet all these requirements.
Our five-strain Adult Formula CP-1 capsules have a total bacterial
count of 50 billion microorganisms per capsule at date of expiration.
This is verified by certified laboratory analysis. Upon request,
we will be pleased to share with you the most recent independent
laboratory test results, that indicated 73 billion per capsule.
Adult Formula CP-1's high bacterial count, broad-spectrum formulation
and high viability of friendly bacteria all contribute to its
effectiveness. It is dairy free, hypoallergenic, and does not
contain any artificial colors, flavors, preservatives, sugar,
gluten or FOS. Our custom probiotic powder formulations range
from 100 to 400 billion microorganisms per gram, the highest potency
of any probiotic formulation available in the market today.
We do not use prebiotics, such as fructooligosacharides (F0S)
or inulin, in our formulations, with a view to eliminating possible
adverse reactions by highly allergic and sensitive individuals,
such as Candida or irritable bowel disease (IBD) patients. Most
FOS in todays market contain 5-40% free sugar. We suggest
getting FOS from vegetables such as onion, garlic, asparagus,
dandelion, artichokes and leeks, which have many additional health
promoting and nutritional benefits..
Growth
characteristics of probiotics appear to be species-specific and
depend on the amount ingested and duration administered. The greater
the bacterial imbalance in the digestive system, the higher the
dosage required for positive and measurable results.
Dosage differs from individual to individual. You must find the
appropriate dosage for you, which may be 1, 2 or 6 of our Adult
Formula CP-1 capsules per day. We suggest gradually increasing
probiotic dosage from one capsule (50 billion cfus) to a
maximum of six capsules per day to find the appropriate dosage.
Like a fingerprint, the composition of the intestinal microflora
is quite different from one human to another, which is an immediate
obstacle in manipulating it. Hence the appropriate dosage of probiotics
needs to be determined individually.
How you use a probiotic depends on why you are taking it. If the
primary purpose for taking the probiotic is to aid digestion,
then you must take it with meals. If the goal is to have the probiotic
reach the lower intestinal tract, then it may be more appropriate
to take it between meals, with a full glass of water. Water dilutes
the stomach acids and moves the organisms quickly into the intestinal
tract. Probiotics can also be used for both purposes by taking
some with meals and some between meals(14).
We suggest taking probiotics first thing in the morning and at
bedtime, with water.
There will, inevitably, be some loss of activity of probiotics
during the passage from stomach to colon, due to pH, bile acids
and other factors. Successful colonization depends very much on
optimal dosing and can be very strain dependent. That is the reason
a high potency multi-strain formulation such as our Adult Formula
CP-1 and probiotic powders become effective. The gastrointestinal
tract harbors about 100 trillion bacteria, more than 90% in the
colon. The intake of merely a few billion probiotic friendly
bacteria a day is unlikely to make much of a difference
in most instances. Also please note that our probiotic strains
are very much acid resistant.
OUR PRODUCTS SHOULD BE REFRIGERATED TO RETAIN MAXIMUM POTENCY.
Keeping our product at room temperature for 2-3 weeks, however,
will have little impact on the bacterial count. We have studied
the effect of temperature on our CP-1 capsules. Storing one bottle
in an un-air-conditioned room, in the summer, for five months,
resulted in bacterial count reduction from 60 billion cfu's per
capsule to 30 billion cfu's per capsule, indicating very good
temperature stability of our probiotics.
For
further information, comments or ordering
of our QUALITY probiotic dietary supplements please
review our informative web site, and do not hesitate to Contact
Us by phone, fax, e-mail
or our online
store.
|
| |
|